| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income, net | 1,423 | 3,849 | 3,709 | 4,405 |
| (loss) income before income taxes | -7,769 | -6,775 | -11,266 | 157 |
| Benefit from income taxes | -2,291 | -1,192 | 136 | -784 |
| Net loss | - | -5,583 | - | - |
| Net (loss) income | -5,478 | - | -11,402 | 941 |
| Net (loss) income, basic | -5,478 | -5,583 | -11,402 | 941 |
| Net income (loss), diluted | - | - | - | 941 |
| Weighted-average shares used in calculating net (loss) income per share, basic(in shares) | 127,547,859 | 126,934,294 | 128,339,481 | 131,003,744 |
| Weighted-average shares used in calculating net (loss) income per share, diluted (in shares) | 127,547,859 | 126,934,294 | 128,339,481 | 132,785,552 |
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)